Advertisement

  

International News

PEPFAR ART Cost Model Data Presented to PEPFAR Scientific Advisory Board

From Henry J. Kaiser Family Foundation

October 6, 2011

"For every 1,000 patient-years of PEPFAR-supported HIV treatment provided, 228 fewer HIV patients die, 449 fewer children become orphans, 61 fewer sexual HIV transmissions occur and 26 fewer 'vertical' transmissions (e.g. mother-to-child) occur," John Blanford of the CDC told the PEPFAR Scientific Advisory Board in Washington, D.C., on September 14, according to a post in the Center for Global Health Policy's "Science Speaks" blog. According to the blog, "PEPFAR developed the antiretroviral therapy (ART) cost model to estimate resource requirements for treatment scale up, utilizing data from the multi-country PEPFAR ART Costing Project Study and other PEPFAR-supported studies" (Mazzotta, 10/5).

Back to other news for October 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




  
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Keeping HIV Patients on ART Will Have Long-Term Economic Benefits, Study Shows
No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement
Advertisement